Literature DB >> 26158155

The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.

Ren-fie Wang, Bao-Rong Song, Jun-Jie Peng, Guo-Xiang Cai, Fang-Qi Liu, Ming-He Wang, San-Jun Cai, Xu Ye.   

Abstract

BACKGROUND/AIMS: There is disagreement about the prognostic value of serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) in patients who have stage I-III colorectal cancer. Therefore, we investigated the relationship between preoperative serum CEA and CA19-9 levels and clinical outcome in patients with this disease.
METHODOLOGY: The study included 724 patients who had received radical resection for stage I-III colorectal cancer in Fudan University Shanghai Cancer Center. We retrospectively investigated the relationship between patients' characteristics and survival, using univariate and multivariate analyses. In multivariate analysis, factors found significant in the univariate analysis were compared with patients' outcomes.
RESULTS: In univariate analysis, differentiation (P < 0.001), depth of invasion (P < 0.001), number of lymph node metastases (P < 0.001), and elevated levels of CEA (P < 0.001) and CA19-9 (P < 0.001) were closely correlated with patients' survival. In multivariate analysis, the number of lymph node metastases (P < 0.001), preoperative CA19-9 (P = 0.015) and CEA (P = 0.028) values, differentiation (p = 0.040) and depth of invasion (p = 0.039) were independent prognostic factors for survival.
CONCLUSIONS: Preoperative CA19-9 and CEA have independent prognostic values in stage I-III colorectal cancer. Elevation of and both CEA and CA19-9 values predicted the worst outcome.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26158155

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  14 in total

1.  Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery.

Authors:  Tunc Eren; Busra Burcu; Ercument Tombalak; Tugrul Ozdemir; Metin Leblebici; Ibrahim Ali Ozemir; Sedat Ziyade; Orhan Alimoglu
Journal:  J Gastrointest Surg       Date:  2016-02-29       Impact factor: 3.452

2.  High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection.

Authors:  Zhenhai Lu; Jianhong Peng; Zhiqiang Wang; Zhizhong Pan; Yunfei Yuan; Desen Wan; Binkui Li
Journal:  Med Oncol       Date:  2016-10-08       Impact factor: 3.064

Review 3.  CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.

Authors:  Yu Xin; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-05-01       Impact factor: 6.831

4.  A clinical nomogram incorporating salivary Desulfovibrio desulfuricans level and oral hygiene index for predicting colorectal cancer.

Authors:  Yao Wang; Yao Zhang; Zheng Wang; Jian Tang; Dong-Xing Cao; Yun Qian; Yuan-Hong Xie; Hai-Ying Chen; Ying-Xuan Chen; Zhao-Fei Chen; Jing-Yuan Fang
Journal:  Ann Transl Med       Date:  2021-05

Review 5.  Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Authors:  Stefan Holdenrieder; Lance Pagliaro; David Morgenstern; Farshid Dayyani
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

6.  Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.

Authors:  Xiao-Ming Sun; Yuan-Hong Xie; Qin-Yan Gao; Guo-Xiang Cai; Tian-Hui Zou; Hui-Min Chen; Si-Yi Yu; Yi-Wen Qiu; Wei-Qi Gu; Xiao-Yu Chen; Yun Cui; Danfeng Sun; Zhan-Ju Liu; San-Jun Cai; Jie Xu; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  EBioMedicine       Date:  2017-10-04       Impact factor: 8.143

7.  Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.

Authors:  Peizhan Chen; Bin Li; Yan Zhu; Wei Chen; Xin Liu; Mian Li; Xiaohua Duan; Bin Yi; Jinghan Wang; Chen Liu; Xiangji Luo; Xiaoguang Li; Jingquan Li; Lijian Liang; Xiaoyu Yin; Hui Wang; Xiaoqing Jiang
Journal:  Oncotarget       Date:  2016-06-14

Review 8.  Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors.

Authors:  Zhonghua Ma; Hesuyuan Huang; Yetao Xu; Xuezhi He; Jirong Wang; Bingqing Hui; Hao Ji; Jing Zhou; Keming Wang
Journal:  Onco Targets Ther       Date:  2017-09-25       Impact factor: 4.147

Review 9.  BANCR: a novel oncogenic long non-coding RNA in human cancers.

Authors:  Yifan Zou; Jianfa Li; Yincong Chen; Huizhong Xiao; Fuyou Zhang; Dan Yu; Kewang Luo
Journal:  Oncotarget       Date:  2017-10-24

10.  FOLFOX regimen plus dendritic cells-cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis.

Authors:  Yan Liu; Zhong Zheng; Qixin Zhang; Xinling Zhou; Yikuan Feng; Anquan Yan
Journal:  Onco Targets Ther       Date:  2017-05-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.